Risk Factors for Predicting Osteoporosis in Patients Who Receive Thyrotropin Suppressive Levothyroxine Treatment for Differentiated Thyroid Carcinoma.

Autor:	Soydal, Çiğdem, Özkan, Elgin, Nak, Demet, Elhan, Atilla Halil, Küçük, Nuriye Özlem, Kır, Metin Kemal
Předmět:	THYROTROPIN THYROID cancer THERAPEUTICS OSTEOPOROSIS BONE density DISEASE risk factors
Zdroj:	Molecular Imaging & Radionuclide Therapy; Jun2019, Vol. 28 Issue 2, p69-75, 7p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu